Share

Networks

Clinical Studies (3)

  • Vicente-Valor : Study aims to evaluate the effectiveness and safety of remdesivir and SARS-CoV-2 monoclonal antibodies in preventing COVID-19 progression in patients with hematological malignancies and mild-to-moderate disease in real clinical practice
  • García-Piqueras : Study aims to characterise patients, their demographics and clinical presentation, presenting to the Dermatology emergency room with a mpox infection in a tertiary hospital in Madrid, Spain
  • E-APLICOV-PC : Study aims to evaluate the impact of plitidepsin treatment on reducing viral load and accelerating patient recovery following SARS-CoV-2 infection. To assess whether this treatment could have a relevant impact on the emergence of long-term sequelae resulting from the infection

Study Data

  • Adults (18-64 years)
  • General population
  • Elderly (≥65 years)
  • Fragile population
  • Immunocompromised host
  • Hospital
  • Outpatient clinic
  • SARS-CoV-2
  • Monkeypox virus
  • Post COVID-19 condition
  • Acute COVID-19
  • Mpox
  • Pharmacological intervention
  • Antivirals
  • Remdesivir
  • Plitidepsin

Other information

If you would like to contact the site, please email: ccb@ateneo.univr.it

The data is updated up to